Medical Devices — Amortization

Business Segments · Amortization

Johnson & Johnson Medical Devices — Amortization remained flat by 0.0% to $500.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $500.00M to $500.00M.

Analysis

StatementSegment
CategoryEfficiency
SignalContext dependent
VolatilityStable
First reportedQ1 2018
Last reportedQ3 2025

How to read this metric

Higher amortization often reflects significant past acquisition activity or heavy investment in intellectual property.

Detailed definition

This represents the periodic expense recognized for the allocation of the cost of intangible assets, such as patents and...

Peer comparison

Commonly reported as part of segment-level depreciation and amortization in financial disclosures for M&A-active firms.

Metric ID: jnj_segment_medtech_amortization

Historical Data

14 periods
 Q2 '21Q3 '21Q4 '21Q2 '22Q3 '22Q4 '22Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25
Value$300.00M$300.00M$300.00M$300.00M$300.00M$300.00M$400.00M$400.00M$400.00M$400.00M$500.00M$500.00M$500.00M$500.00M
QoQ Change+0.0%+0.0%+0.0%+0.0%+0.0%+33.3%+0.0%+0.0%+0.0%+25.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+0.0%+0.0%+33.3%+33.3%+0.0%+25.0%+25.0%+25.0%+0.0%
Range$300.00M$500.00M
CAGR+17.0%
Avg YoY Growth+14.2%
Median YoY Growth+12.5%
Current Streak13+ quarters growth

Frequently Asked Questions

What is Johnson & Johnson's medical devices — amortization?
Johnson & Johnson (JNJ) reported medical devices — amortization of $500.00M in Q3 2025.
How has Johnson & Johnson's medical devices — amortization changed year-over-year?
Johnson & Johnson's medical devices — amortization decreased by 0.0% year-over-year, from $500.00M to $500.00M.
What does medical devices — amortization mean?
The non-cash expense related to the gradual write-down of intangible assets like patents and acquired technology.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.